Dr Reddy's Laboratories Ltd (NYSE:RDY)
| 66.02 Delayed Data As of Oct 15 |  +0.56 / +0.86%Today’s Change | 57.54 Today|||52-Week Range 75.50 | -7.39% Year-to-Date |
Latest RDY News | Press Releases
No recent news for Dr Reddy's Laboratories Ltd.
Today’s Trading
| Previous close | 65.46 |
| Today’s open | 66.04 |
| Day’s range | 65.66 - 66.10 |
| Volume | 69,447 |
| Average volume (3 months) | 121,508 |
| Market cap | $10.9B |
Data as of 3:59pm ET, 10/15/2021
Growth & Valuation
| Earnings growth (last year) | -15.59% |
| Earnings growth (this year) | +45.19% |
| Earnings growth (next 5 years) | +22.00% |
| Revenue growth (last year) | +3.79% |
| P/E ratio | 48.0 |
| Price/Sales | 4.00 |
| Price/Book | 4.59 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BHCValeant Pharmaceutic... | +0.06 | +0.21% |
| ---- | ||
| MRTXMirati Therapeutics ... | +2.93 | +1.67% |
| BHVNBiohaven Pharmaceuti... | -1.17 | -0.87% |
Data as of 4:00pm ET, 10/15/2021
Financials
| Next reporting date | October 29, 2021 |
| EPS forecast (this quarter) | $0.56 |
| Annual revenue (last year) | $2.6B |
| Annual profit (last year) | $232.2M |
| Net profit margin | 9.09% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Hyderabad, Telangana |
Forecasts
